Inventor · disambiguated record
Carl R. Merril
Also filed as: MERRIL CARL · MERRIL CARL R
30 granted patents·21 pending applications·839 citations·filing 1982–2024
98Inventor score
Files withUS HEALTH14ADAPTIVE PHAGE THERAPEUTICS INC8EXPONENTIAL BIOTHERAPIES INC6PANACEA PHARMACEUTICALS INC5MONOCLONETICS INT4
Top patents by PatentIndex Score
51 records- 0194US5688501AAntibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 1996·Granted Nov 18, 1997·112 cites·16 claims
- 0292US4555490ARapid visualization system for gel electrophoresisUS HEALTH·Filed 1984·Granted Nov 26, 1985·57 cites·10 claims
- 0387US5811093ABacteriophage genotypically modified to delay inactivations by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 1996·Granted Sep 22, 1998·72 cites·4 claims
- 0487US4405720ASilver stains for protein in gelsUS HEALTH·Filed 1982·Granted Sep 20, 1983·48 cites·16 claims
- 0586US7332307B2Antibacterial therapy with bacteriophage physico-chemically altered by pegylation to delay inactivation by the host defense systemUS HEALTH·Filed 2003·Granted Feb 19, 2008·12 cites·2 claims
- 0685US7399753B2Trans-splicing mediated photodynamic therapyVIRXSYS CORP·Filed 2003·Granted Jul 15, 2008·13 cites·15 claims
- 0784US5766892AAntibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system together with an antibioticEXPONENTIAL BIOTHERAPIES INC·Filed 1995·Granted Jun 16, 1998·41 cites·1 claims
- 0882US5468610AThree highly informative microsatellite repeat polymorphic DNA markersUS HEALTH·Filed 1993·Granted Nov 21, 1995·73 cites·12 claims
- 0981US5660812AAntibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 1995·Granted Aug 26, 1997·32 cites·1 claims
- 1079US9744223B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2013·Granted Aug 29, 2017·4 cites·9 claims
- 1179US5817797ASequencing DNA; a modification of the polymerase chain reactionUS HEALTH·Filed 1988·Granted Oct 6, 1998·27 cites·7 claims
- 1279US5369004AFive highly informative microsatellite repeat polymorphic DNA markersUS HEALTH·Filed 1992·Granted Nov 29, 1994·59 cites·4 claims
- 1378US6740492B2High sensitivity phage display biomolecule detectionUS HEALTH·Filed 2001·Granted May 25, 2004·5 cites·5 claims
- 1478US5378602AHighly informative microsatellite repeat polymorphic DNA markers twenty-[seven]sixUS HEALTH·Filed 1991·Granted Jan 3, 1995·76 cites·4 claims
- 1574US7163818B2Bacteriophage having multiple host rangeUS HEALTH·Filed 2003·Granted Jan 16, 2007·7 cites·3 claims
- 1673US7521479B2Methods of treating prion disease in mammalsPANACEA PHARMACEUTICALS INC·Filed 2001·Granted Apr 21, 2009·3 cites·14 claims
- 1770US5844097AMethods for the diagnosis of peripheral nerve damageMONOCLONETICS INT·Filed 1995·Granted Dec 1, 1998·37 cites·2 claims
- 1869US11911345B2Phage dispensing systemADAPTIVE PHAGE THERAPEUTICS INC·Filed 2018·Granted Feb 27, 2024·1 cites·28 claims
- 1969US2024108551A1Phage dispensing systemADAPTIVE PHAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2068US4892814AMethod for distinguishing Creutzfeldt-Jakob disease from other dementiasUS HEALTH·Filed 1987·Granted Jan 9, 1990·28 cites·3 claims
- 2165US4940659AScreening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndromeMONOCLONETICS INT·Filed 1987·Granted Jul 10, 1990·23 cites·4 claims
- 2265US4703016ASilver stain for rapid, quantitative detection of polypeptides and nucleic acidsUS HEALTH·Filed 1986·Granted Oct 27, 1987·23 cites·5 claims
- 2363US10702591B2Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylasePANACEA PHARMACEUTICALS INC·Filed 2017·Granted Jul 7, 2020·0 cites·6 claims
- 2461US2024279620A1Method for purification of bacteriophage particlesADAPTIVE PHAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2559US2005063957A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemFiled 2004·Application pending·0 cites
- 2658US2009203143A1Trans-splicing mediated photodynamic therapyVIRXSYS CORP·Filed 2008·Application pending·0 cites
- 2758US2020246443A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2857US5583201AMethods for diagnosis of peripheral nerve damageMONOCLONETICS INT·Filed 1994·Granted Dec 10, 1996·18 cites·1 claims
- 2957US2004161411A1Antibacterial therapy with bacteriophage genotypically modified to delay inactiovation by the host defense systemFiled 2003·Application pending·0 cites
- 3056US4508820AMethod for simultaneously monitoring turnover rate in multiple proteinsUS HEALTH·Filed 1984·Granted Apr 2, 1985·14 cites·4 claims
- 3154US5429947ADiagnosing Alzheimer's disease and schizophreniaFiled 1992·Granted Jul 4, 1995·18 cites·5 claims
- 3253US12006517B2Method for purification of bacteriophage particlesADAPTIVE PHAGE THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·0 cites·19 claims
- 3352US5364793AMethods for the diagnosis of peripheral nerve damageMONOCLONETICS INT·Filed 1992·Granted Nov 15, 1994·15 cites·4 claims
- 3452US2017072034A1Therapeutic cancer vaccine targeted to haah (aspartyl-[asparaginyl]-beta-hydroxylase)PANACEA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3552US2001043917A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemFiled 2001·Application pending·0 cites
- 3652US2001026795A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 2001·Application pending·0 cites
- 3752US2021315197A1Preservation of phage concentration in clinical samplesADAPTIVE PHAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3850US5292665ACatalyst for preparing polyacrylamide gel which improves the detection of biomaterials by silver stainingUS ARMY·Filed 1992·Granted Mar 8, 1994·12 cites·15 claims
- 3950US2007207167A1Immunologically enhanced recombinant vaccinesMERRIL CARL R·Filed 2006·Application pending·0 cites
- 4050US2001043924A1Antibacterial therapy with bacteriophage physico-chemically altered to delay inactivation by the host defense systemEXPONENTIAL BIOTHERAPIES INC·Filed 2001·Application pending·0 cites
- 4150US2021332419A1Monitoring host cell contamination of virus-based biological productsADAPTIVE PHAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4248US2014271689A1Therapeutic Cancer Vaccine Targeted to HAAH (Aspartyl-[Asparaginyl]-beta-Hydroxylase)BISWAS BISWAJIT·Filed 2013·Application pending·0 cites
- 4347US2021369635A1Novel methods of vaccination using icosahedral phageADAPTIVE PHAGE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4445US5721100AThree highly informative microsatellite repeat polymorphic DNA markersUS HEALTH·Filed 1995·Granted Feb 24, 1998·6 cites·12 claims
- 4545US2021065844A1Methods to determine the sensitivity profile of a bacterial strain to a therapeutic compositionADAPTIVE PHAGE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4643US2005118567A1Method for determining sensitivity to a bacteriophageFiled 2003·Application pending·0 cites
- 4739US2002177614A1Methods for treating nuerodegenerative diseases including alzheimer'sFiled 2001·Application pending·0 cites
- 4837US2009155768A1Reporter plasmid phage packaging system for detection of bacteriaSCHOLL DEAN·Filed 2005·Application pending·0 cites
- 4934US5861504AEleven highly informative microsatelite repeat polymorphic DNA markersUS HEALTH·Filed 1992·Granted Jan 19, 1999·3 cites·5 claims
- 5031US2003026785A1Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense systemFiled 1997·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Carl R. Merril files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →